NCT03674814 2026-03-04Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate CancerUniversity of ChicagoPhase 1 Active not recruiting35 enrolled
NCT05726292 2026-03-04A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate CancerUniversity of ChicagoPhase 2 Recruiting90 enrolled